Seipelt, I. | IICIMED

Seipelt, I.

Publications

P153

Med. Chem. Commun. 2016, 7, 224-229.

Efficient synthesis of novel disubstituted pyrido[3,4-b]pyrazines for the design of protein kinase inhibitors.

Antoine, M. | Schuster, T. | Seipelt, I. | Aicher, B. | Teifel, M. | Günther, E. | Gerlach, M. | Marchand, P.

doi: 10.1039/C5MD00424A

P127

Bioorg. Med. Chem. Lett. 2014, 24, 3748-3752.

Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells.

Defaux, J. | Antoine, M. | Logé, C. | Le Borgne, M. | Schuster, T. | Seipelt, I. | Aicher, B. | Teifel, M. | Günther, E. | Gerlach, M. | Marchand, P.

P124

ChemMedChem 2014, 9, 217-232.

Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors. 

Defaux, J. | Antoine, M. | Le Borgne, M. | Schuster, T. | Seipelt, I. | Aicher, B. | Teifel, M. | Günther, E. | Gerlach, M. | Marchand, P.

P98

Synthesis, 2012, 44, 69-82.  

A convenient synthesis of novel 2,8-disubstituted pyrido[3,4-b]pyrazines possessing biological activity.

Antoine, M. | Gerlach, M. | Günther, E. | Schuster, T. | Czech, M. | Seipelt, I. | Marchand, P.

Autres publications scientifiques

Brevets

B15.

Novel Naphthyridine derivatives and the use thereof as kinase inhibitors.

Gerlach, M. | Schuster, T. | Marchand, P. | Defaux, J. | Seipelt, I. | Polymeropoulos, E. | Müller, G. | Günther, E.

PCT Int. Appl. WO 2011064250, 2011.

Thèse